ArticleVideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy2026
Percutaneous endoscopic vacuum therapy for treatment of severe gastric staple line dehiscence after surgical bypass revision.
Article in VideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Gastric leaks and gastrocutaneous fistulas (GCFs) are severe adverse events of gastric bypass surgery, often difficult to manage with conventional treatments. Methods: We present the case of a 63-year-old woman who, after revisional surgery for a gastrogastric fistula and weight regain after initial gastric bypass, developed gastric staple line dehiscence and 2 GCFs. Results: Initial endoscopic vacuum therapy using a nasogastric tube was unsuccessful because of patient discomfort. Subsequently, percutaneous endoscopic vacuum therapy (P-EVT) was performed by placing multiple foam devices through the GCFs under endoscopic and fluoroscopic guidance. Weekly tube exchanges were conducted with endoscopic guidance and later percutaneously. The perigastric cavity resolved, and after P-EVT removal, an esophageal stent was placed to facilitate GCF closure. Conclusions: P-EVT represents a novel, less-invasive approach for managing complex gastric leaks, enabling the use of larger and multiple sponges, less-invasive tube exchanges, and a reduced need for frequent endoscopy, thereby enhancing patient comfort and treatment efficacy.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.